Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5709194 | The Journal of Arthroplasty | 2017 | 6 Pages |
Abstract
Systemic administration of TXA can effectively reduce the postoperative blood loss which results in lower rate of transfusion requirement and wound hematoma in minimally invasive TKA patients when rivaroxaban is used for thromboprophylaxis. Rivaroxaban has a high rate of bleeding complications when used alone in TKA patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Jun-Wen MD, Bradley MD, ScD, Po-Chun MD, Shih-Hsiang MD, Chung-Cheng MD, Feng-Chih MD,